Skip to content
(RS)-lenalidomide

Structure via PubChem · Public domain (PubChem)

EntityQ425681· pop 23· linked from 250 articles

(RS)-lenalidomide

Sign in to save

Also known as CC-5013, CDC-501, 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, IMiD3, CDC 501, IMid-1, 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione, Lenalidomide

Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, various indolent lymphomas, and myelodysplastic syndromes (MDS). For multiple myeloma, it is a first-line treatment, and is given with dexamethasone. It is taken by mouth.

Key facts

Drug.H
13
Drug.N
3
Drug.O
3
Drug.Watchedfields
changed
Drug.verifiedrevid
459429828
Drug.image
Lenalidomide enantiomers.svg
Drug.image_class
skin-invert-image
Drug.width
200
Drug.chirality
Racemic mixture
Drug.tradename
Revlimid, Linamide, others
Drug.MedlinePlus
a608001
Drug.licence_EU
yes
Drug.DailyMedID
Lenalidomide
Drug.pregnancy_AU
X
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
L04
Drug.ATC_suffix
AX04
Drug.legal_AU
S4

via Wikipedia infobox

Chemical data

Formula
C13H13N3O3
Molecular weight
259.26 g/mol
IUPAC name
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
SMILES
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
InChIKey
GOTYRUGSSMKFNF-UHFFFAOYSA-N
XLogP
-0.5
Polar surface area
92.5 Ų
H-bond donors
2
H-bond acceptors
4
Formal charge
0

via PubChem

Wikidata facts

Mass
259.095691
Show 5 more facts
chemical formula
C₁₃H₁₃N₃O₃
World Health Organisation international non-proprietary name
lenalidomide
canonical SMILES
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
defined daily dose
10
Commons category
Lenalidomide
Sources (7)

via Wikidata · CC0

~10 min read

Article

19 sections
Contents
  • Medical uses
  • Multiple myeloma
  • Myelodysplastic syndromes
  • Follicular Lymphoma
  • Mantle cell lymphoma
  • AL amyloidosis
  • Adverse effects
  • Teratogenicity
  • Venous thromboembolism
  • Stevens-Johnson syndrome
  • FDA ongoing safety review
  • Mechanism of action
  • Synthesis
  • History
  • Society and culture
  • Legal status
  • Economics
  • Price increases
  • References

Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, various indolent lymphomas, and myelodysplastic syndromes (MDS). For multiple myeloma, it is a first-line treatment, and is given with dexamethasone. It is taken by mouth.

Common side effects include diarrhea, itchiness, joint pain, fever, headache, and trouble sleeping. Severe side effects include low blood platelets, low white blood cells, and blood clots. The dose may need to be adjusted in people with kidney problems. Lenalidomide is closely related to thalidomide, which is known to cause severe birth defects, so its use during pregnancy is very likely to harm the fetus.

Gallery (3)

Connections

Categories